CNS Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $18,865,108.
Profit Margin
| 2017 | 0 | -526.46K | |
|---|---|---|---|
| 2018 | 0 | -7.39M | |
| 2019 | 0 | -3.91M | |
| 2020 | 0 | -9.45M | |
| 2021 | 0 | -14.04M | |
| 2022 | 0 | -15.28M | |
| 2023 | 0 | -18.85M |
CNSP Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 4.13K | 11.75K | 13.07K | 11.09K | 1.95K | 0 | 0 |
Gross profit | -4.13K | -11.75K | -13.07K | -11.09K | -1.95K | 0 | 0 |
Operating exp. | |||||||
Research and development | 14.09M | 9.30M | 9.34M | 5.06M | 1.85M | 21.26K | 32.63K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | -255.45K |
Total operating expenses | 18.86M | 15.26M | 14.02M | 9.45M | 3.83M | 881.78K | 215.10K |
Operating income | -18.86M | -15.26M | -14.02M | -9.45M | -3.83M | -881.78K | -215.1K |
Other income (expenses), net | 13.88K | -7.02K | -9.28K | -3.26K | -44.23K | -6.46M | -4.26K |
Income before tax | -18.85M | -15.27M | -14.03M | -9.45M | -3.87M | -7.39M | -219.36K |
Income tax expense | 0 | 7.02K | 9.28K | 3.26K | 42.27K | 46.69K | -516.25K |
Net income | -18.85M | -15.28M | -14.04M | -9.45M | -3.91M | -7.39M | -526.46K |
Earnings per share | |||||||
Basic EPS | -251.35 | -11.22 | -15.99 | -859.81 | -7.15 | -16.83 | -48.01 |
Diluted EPS | -250.19 | -11.22 | -15.99 | -853.68 | -7.15 | -16.83 | -48.01 |
| Data source | Data source | Data source | Data source | Data source |